Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

As an experienced laboratory professional, Peter Wegwerth was well-suited to pivot from his work in Mayo Clinic's Biochemical Genetics Laboratory to redeployment in a COVID-19 testing lab when the pandemic hit in 2020.

This week’s research roundup features a study on positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing.

Top highlights include: New CDC guidance for vaccinated adults, the importance of the second dose, and who's at higher risk for serious symptoms.

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., reflect on the dramatic advances that have taken place in laboratory medicine during the pandemic and what those changes might mean for the future.

The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.

This week’s research roundup features a study on how the CLL-international prognostic index (CLL-IPI) predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.

Andrew McKeon, M.B., B.Ch., M.D., discusses updates that are being made to Mayo Clinic Laboratories' autoimmune profile that will remove some antibodies from those profiles. He describes the rationale behind the updates, reviews which antibodies are involved, and explains how the changes will streamline testing and enhance test interpretation.

Top highlights include: J&J COVID-19 vaccine pause ends, combating allergies during the pandemic, and researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant patients.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the safety of COVID-19 vaccines in light of the recent pause in distribution of the Johnson & Johnson vaccine.

Kae Essler’s behind-the-scenes role managing Mayo Clinic Laboratories’ Client Conversion team may not be highly visible, but her group’s work is crucial to ensuring an easy transition for clients and setting the stage for a productive collaboration going forward.

This week’s research roundup features a study on protocadherin 7-associated membranous nephropathy.